Boston, MA—Patients with cervical and endometrial cancers experience fewer gastrointestinal and genitourinary adverse events and have improved quality of life when they receive intensity-modulated radiation therapy (IMRT) compared with conventional radiation therapy, according to the results of a recent study presented at the 2016 Annual Meeting of the American Society for Radiation Oncology (ASTRO).
Adelaide, Australia—The 2016 Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) Annual Meeting on Supportive Care in Cancer marked the 25th anniversary of MASCC, and the 30th anniversary of ISOO. This year, 1075 delegates from >50 countries attended this international symposium.
Chicago, IL—The anaplastic lymphoma kinase (ALK) mutation is a target for tyrosine kinase therapies in several cancers, including non–small-cell lung cancer (NSCLC). Since 2011, several ALK inhibitors have been approved, and more are in the pipeline, but many questions remain for managing patients with ALK-positive NSCLC.
Chicago, IL—Maintaining a clean room compliant with US Pharmacopeial Convention Chapter 800 (USP 800) can come with a significant price tag, but noncompliance can drive up costs to oncology practices and institutions. However, certain measures can contribute to the successful construction, renovation, and maintenance of hazardous drug sterile compounding spaces in an oncology setting, according to Ryan A. Forrey, PharmD, MS, FASHP, Director of Pharmacy, Emory University Hospital Midtown, Atlanta, GA.
Chicago, IL—A clear set of standard operating procedures is at the heart of US Pharmacopeial Convention Chapter 800 (USP 800) compliance, according to Carol Yarrington, PharmD, BCOP, Oncology and Infusion Pharmacy Coordinator and Clinical Oncology Pharmacist, St. Joseph Mercy Health System, Ann Arbor, MI.
New data from an interim analysis of the head-to-head, open-label, phase 3, Japanese study J-ALEX, show that alectinib (Alecensa) significantly improved progression-free survival (PFS) compared with crizotinib (Xalkori) in the frontline setting, according to Hiroshi Nokihara, MD, PhD, of the National Cancer Center Hospital, Tokyo, Japan.
- Novel Antibody Shows Promising Results in Gastric Cancer
- Nivolumab Improves Outcomes in Patients with Anal Cancer
- Brentuximab as an Alternative to Radiation Therapy
- Adjuvant Temozolomide for Rare Brain Cancer
- Internet-Mediated Application Improves Survival in Patients with Lung Cancer
- Burnout Among Oncology Physician Assistants
- Clinicians’ Perception of Risk and Quality of Life Affect Patient Outcomes
The 2016 Annual Congress of the Oncology Nursing Society marked the 41st anniversary of the organization. More than 3000 registrants met at the newly renovated Henry B. Gonzalez Convention Center in San Antonio, TX, just steps from the famed San Antonio River Walk.
Results 31 - 40 of 287